Sitagliptin "Laurus" 100 mg filmovertrukne tabletter Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "laurus" 100 mg filmovertrukne tabletter

laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg

Sitagliptin "Laurus" 50 mg filmovertrukne tabletter Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "laurus" 50 mg filmovertrukne tabletter

laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg

Sitagliptin "Reddy" 100 mg filmovertrukne tabletter Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "reddy" 100 mg filmovertrukne tabletter

reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg

Sitagliptin "Reddy" 50 mg filmovertrukne tabletter Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "reddy" 50 mg filmovertrukne tabletter

reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg

Galvus Unió Europea - danès - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Unió Europea - danès - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Xiliarx Unió Europea - danès - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).